Functional Characterization of Clinically-Relevant Rare Variants in ABCG2 Identified in a Gout and Hyperuricemia Cohort
Yu Toyoda(University of Tokyo Hospital), Blanka Stibůrková(Charles University), Markéta Pavlı́ková(Charles University), Vladimír Krylov(Charles University), Keito Morimoto(University of Tokyo Hospital), Hirotaka Matsuo(National Defense Medical College), Andrea Mančíková(Charles University), Karel Pavelká(Institute of Rheumatology), Hiroshi Suzuki(University of Tokyo Hospital), Kateřina Pavelcová(Institute of Rheumatology), Jana Bohatá(Institute of Rheumatology), Tappei Takada(University of Tokyo Hospital)
Cited by 70
Related Papers
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
|The Lancet|2004|1.8k
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
|Annals of the Rheumatic Diseases|2013|1.4k
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
|Annals of the Rheumatic Diseases|2011|988
Decreased extra-renal urate excretion is a common cause of hyperuricemia
|Nature Communications|2012|703